Skip to main content
Article
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)
Annals of the Rheumatic Diseases (2017)
  • Vibeke Strand, Stanford University
  • Philip Mease, University of Washington
  • Laure Gossec, University of Paris
  • Ori Elkayam, Tel Aviv University
  • Filip van den Bosch, Ghent University
  • James Zuazo, Novartis
  • Luminita Pricop, Novartis
  • Shephard Mpofu, Novartis
Publication Date
January 1, 2017
DOI
10.1136/annrheumdis-2015-209055
Citation Information
Vibeke Strand, Philip Mease, Laure Gossec, Ori Elkayam, et al.. "Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)" Annals of the Rheumatic Diseases Vol. 76 Iss. 1 (2017) p. 203 - 207
Available at: http://works.bepress.com/philip-mease/75/